Compare ODC & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODC | CTKB |
|---|---|---|
| Founded | 1941 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 706.2M | 652.1M |
| IPO Year | N/A | 2021 |
| Metric | ODC | CTKB |
|---|---|---|
| Price | $62.49 | $4.20 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.70 |
| AVG Volume (30 Days) | 75.6K | ★ 879.6K |
| Earning Date | 03-10-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.27% | N/A |
| EPS Growth | ★ 17.33 | N/A |
| EPS | ★ 3.63 | N/A |
| Revenue | ★ $478,113,000.00 | $196,828,000.00 |
| Revenue This Year | N/A | $0.15 |
| Revenue Next Year | N/A | $5.20 |
| P/E Ratio | $17.73 | ★ N/A |
| Revenue Growth | ★ 5.29 | N/A |
| 52 Week Low | $41.37 | $2.37 |
| 52 Week High | $69.76 | $6.18 |
| Indicator | ODC | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 61.23 | 29.49 |
| Support Level | $57.35 | $4.09 |
| Resistance Level | $67.25 | $5.29 |
| Average True Range (ATR) | 1.64 | 0.25 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 52.12 | 9.54 |
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.